Using Incentives to Improve Quality in Health Care: Theory, Literature Review, and Ongoing Research R. Adams Dudley, MD, MBA Institute for Health Policy.

Slides:



Advertisements
Similar presentations
Blending Supply-Side Approaches with Consumerism Paul B. Ginsburg, Ph.D. Presentation to Second National Consumer-Driven Healthcare Summit, September 26,
Advertisements

PAYING FOR PERFORMANCE In PUBLIC HEALTH: Opportunities and Obstacles Glen P. Mays, Ph.D., M.P.H. Department of Health Policy and Administration UAMS College.
Study Objectives and Questions for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Donald T. Simeon Caribbean Health Research Council
Delivering care to the underserved: Increasing the Numbers of Minority Physicians Ruben Gonzalez MD CCRMC.
Advanced Health Models and Meaningful Use Workgroup: Roadmap Charge Overview Paul Tang, chair Joe Kimura, co-chair.
Research Methodology Lecture No : 11 (Goodness Of Measures)
Quality-Based Purchasing: Challenges, Tough Decisions, and Options R. Adams Dudley, MD, MBA Support: Agency for Healthcare Research and Quality, California.
Deductible-based Health Insurance Plans: Are Complex Deductible Exemptions Confusing Patients? Mary Reed, DrPH Center for Health Policy Studies, Kaiser.
Work motivation among healthcare professionals in the Saudi hospitals Presented by Nouf Sahal Al-Harbi Supervised by: Dr. Saad Al-Ghanim 2008.
BUSINESS AND FINANCIAL LITERACY FOR YOUNG ENTREPRENEURS: EVIDENCE FROM BOSNIA-HERZEGOVINA Miriam Bruhn and Bilal Zia (World Bank, DECFP)
Incorporating considerations about equity in policy briefs What factors are likely to be associated with disadvantage? Are there plausible reasons for.
Basma Y. Kentab MSc. Department of Clinical Pharmacy May 2014.
Department of Health and Human Services Measuring Clinical Lab Ordering Quality: Theory and Practice Steven M. Asch MD MPH VA, RAND, UCLA April 29, 2005.
America’s Health Insurance Plans Health Insurance Plans Approaches to Asthma Management: 2006 Assessment Supported through a cooperative agreement with.
1 Integrated Multi-Level Approaches to Asthma Management Noreen M. Clark, Ph.D. Dean & Marshall H. Becker Professor University of Michigan School of Public.
What will it Take to Improve Care for Chronic Illness for the Population? Ed Wagner, MD, MPH MacColl Institute for Healthcare Innovation Center for Health.
Use of Commercial EMRs for Quality Reporting & Improvement: The Experience of Physician Practices Joy M. Grossman, PhD and Hoangmai Pham, MD, MPH AcademyHealth.
Racial/Ethnic Disparities in Health Care: Narrowing the Gap through Solutions Joseph R. Betancourt, M.D., M.P.H. Director, The Disparities Solutions Center.
The Evidence for Using Incentives to Improve Quality in Health Care R. Adams Dudley, MD, MBA Institute for Health Policy Studies University of California,
Pay-for-Performance and Consumer Incentives: The Available Evidence and AHRQ Resources Supported by: Agency for HealthCare Research and Quality U.S. Department.
Provider Peer Grouping: Project Overview James I. Golden, PhD Director, Division of Health Policy Minnesota Department of Health SCI National Meeting May.
A Summary Of Key Findings From A National Survey Of Voters. #07160.
Public Health Systems Research: What We Know and Need to Learn Glen P. Mays, PhD, MPH Department of Health Policy & Management UAMS College of Public Health.
Pay-for-Performance: A Decision Guide for Purchasers Guide Prepared for: Agency for HealthCare Research and Quality U.S. Department of Health and Human.
Intervention Studies Principles of Epidemiology Lecture 10 Dona Schneider, PhD, MPH, FACE.
Paying for Quality Health Care: States’ Roles  March 24, 2011  New Hampshire General Court  Concord NH  Ellen Andrews, PhD  Health Policy Consultant.
Integrated Framework for Reducing Racial and Ethnic Disparities in the Quality of Health Care Marshall H. Chin, MD, MPH, and Don Goldmann, MD University.
3 Key “Do’s” of Public Reporting R. Adams Dudley, MD, MBA Professor of Medicine and Health Policy Support: Agency for Healthcare Research and Quality,
THE SUPPORTED EMPLOYMENT PROGRAMME OPPORTUNITIES AND CHALLENGES TOM RONAYNE WRC SOCIAL AND ECONOMIC CONSULTANTS IASE Conference
Prevention for older people: context, policy and economics Julien Forder.
Attitudes About and Barriers to Adult Immunization Faruque Ahmed, MD, PhD, MPH ( Immunization Services Division Centers for Disease.
Incentives & Outcomes Committee Draft Recommendations Public Employer Health Purchasing Committee October 25, 2010.
The Audit Process Tahera Chaudry March Clinical audit A quality improvement process that seeks to improve patient care and outcomes through systematic.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
Rewarding Performance: Three-Year Results from California's Statewide Pay-for-Performance Experiment Cheryl L. Damberg, PhD, Kristiana Raube, PhD, Stephanie.
Dr. Turki AlBatti,MD. barriers in young adults with type 1 diabetes Glycemic control and adherence behaviors remain low for patients with type 1 diabetes.
Early Parental Satisfaction with Pediatric Care: Does it Improve Immunization of Young Children? Ashley Schempf BS, Cynthia Minkovitz MD MPP Donna Strobino.
Influenza Vaccination Campaign 2003 Dr. Michael Koller QI Director for Primary Care.
Gary J. Young 1 Designing and Implementing Pay-for-Performance Programs: Ongoing Challenges Gary J. Young, J.D., Ph.D. Boston University Presentation for.
NEET Workgroup #3 - Residential Subgroup Snohomish County PUD November 2008.
1 Measurement Challenges in Reducing Disparities in Health Care Sheldon Greenfield, MD Executive Director University of California, Irvine Center for Health.
The MARYLAND HEALTH CARE COMMISSION. Telehealth Landscape Telehealth adoption is increasing 2013: ~ 61 percent of acute care hospitals; ~9 percent of.
Quality Measurement and Gender Differences in Managed Care Populations with Chronic Diseases Ann F. Chou Carol Weisman Arlene Bierman Sarah Hudson Scholle.
Bob Doherty Senior Vice President, Governmental Affairs and Public Policy American College of Physicians March 3, 2009 Designing new payment models for.
Disclosure of Financial Conflicts of Interest in Continuing Medical Education Michael D. Jibson, MD, PhD and Jennifer Seibert, MD University of Michigan.
Forsberg Knezevic EHMA 2008 Stockholm County Council Reimbursements in psychiatry in Sweden – models and experiences Birger Carl Forsberg. MD MPH BSc Milan.
Pay-for-Performance: A Decision Guide for Purchasers Guide Prepared for: Agency for HealthCare Research and Quality U.S. Department of Health and Human.
Pay for Performance in BCBS Plans Nationally June 22, 2005 National Press Club Bruce E. Landon, M.D., M.B.A.
Using Incentives to Improve Quality in Health Care: Key Concepts and Review of the Literature R. Adams Dudley, MD, MBA, Jason Talavera, Harold S. Luft,
Copyright 2012 Delmar, a part of Cengage Learning. All Rights Reserved. Chapter 9 Improving Quality in Health Care Organizations.
Quality Improvement. What is QI? Quality Improvement is a formal approach to the analysis of performance and systematic efforts to improve it. There are.
1 The Effect of Primary Health Care Orientation on Chronic Illness Care Management Julie Schmittdiel, Ph.D., Stephen M. Shortell, Ph.D., Thomas Rundall,
STRATEGIC CHOICES IN PAY-FOR-PERFORMANCE PROGRAMS Pay for Performance Summit February 6, 2006 Professor James C. Robinson University of California, Berkeley.
QualityIncentivesJune Paying for Quality in Integrated Health Systems Douglas Conrad, PhD Barry Saver, MD, MPH Beverly Court, MHA Sarah Heath, MA.
Cost Management & Financial Performance December 14-15, 2015
Strategies to Improve Clinical Practice Through Guidelines: Experience from Recent Studies Michael Cabana (UCSF) Rebecca Beyth (University of Florida)
1 The Relationship between Pay-for- Performance Incentives and Quality Improvement: A Survey of Massachusetts Physician Group Leaders Ateev Mehrotra, Steven.
HEALTHCARE Treatment Delivery: HEALTHCARE Susan Swartz, MD, MPH Center for Tobacco Independence Portland, Maine.
Marketing Research Aaker, Kumar, Day Seventh Edition Instructor’s Presentation Slides.
Cal-ABA 26th Annual Western Regional Conference What We Know About Sustaining Programs? Randy Keyworth Ronnie Detrich Jack States.
Chapter 3 An Overview of the Healthcare Financing System Copyright 2015 Health Administration Press1.
Population Health: Improving Systems, Practices, and Outcomes SCOTT CONFERENCE CENTER OMAHA, NEBRASKA AUGUST 3, 2016.
Foundations of Planning
Readiness Consultations
Vaccination Strategies
BMC Health Service Research 2015 By Gang Nathan Dong PERFORMING WELL IN FINANCIAL MANAGMGMENG AND QUALITY OF CARE.
Provider Peer Grouping: Project Overview
ICARE Trial Survey Post-Analysis
Provider Counseling for Immunizations in Primary Care Settings
Presentation transcript:

Using Incentives to Improve Quality in Health Care: Theory, Literature Review, and Ongoing Research R. Adams Dudley, MD, MBA Institute for Health Policy Studies University of California, San Francisco Support: Agency for Healthcare Research and Quality, California Healthcare Foundation, Robert Wood Johnson Foundation Investigator Award Program

Outline of Talk (Brief) description of a conceptual model of how incentives might work Literature review: What is known now? Research in progress: What will we know soon? Issues with outcomes reports: Can we believe them? Conclusions

Value-Based Purchasing: A Definition Value-Based Purchasing includes tactics that purchasers adopt with the goal of increasing the quality of care received by their beneficiaries These tactics could include: -Using financial or non-financial incentives to directly reward improved provider behavior -Incorporating provider quality information into the selection of providers or plans offered to beneficiaries -Using financial and other incentives to encourage beneficiaries to select higher quality providers

Value-Based Purchasing: A Definition The above VBP tactics do not cover all approaches to improving quality, but include those that purchasers could plausibly implement or cause to be implemented The goals of VBP tactics are to: -Promote value-based competition among providers -Where competition is not feasible, provide a direct stimulus to improve quality and value

Value-Based Purchasing: A Definition There are other quality improvement approaches beyond a purchaser’s direct control: -E.g., introducing guidelines for diabetes or disease management programs for heart failure -Studies of these approaches are numerous and are NOT included in this review  Purchasers might encourage such efforts, however, by agreeing on uniform standards, or supporting processes that consolidate conflicting guidelines

Value-Based Purchasing: A Definition In the review of the literature, we are NOT addressing interventions directed at patients/consumers (e.g., tiered pricing based on quality of provider) -However, there is very little literature here

Conceptual Considerations: Characteristics of the Incentive Characteristics of the incentive are likely to influence providers’ response. Some are obvious, such as: - the magnitude of a financial incentive - proportion of a provider’s practice to which the incentive is applicable

Conceptual Considerations: Characteristics of the Incentive Other characteristics of the incentive may be critical, but have received little attention, e.g.: - the direct cost of complying - the opportunity costs of complying - non-financial factors (e.g., reputational effects) - the presence of competing incentives or guidelines - expected timeframe for performance and stability of the incentive program

Conceptual Considerations: Factors External to the Incentive There may also be factors external to the incentive that influence providers’ responses –Some may predispose a provider to respond (or not), such as:  The general characteristics of the environment (e.g., FFS vs. capitation, number of other incentive programs offered, past relations between providers and plans or purchasers)  The specific characteristics of the physician (e.g., age, work load, income relative to target)

Conceptual Considerations: Factors External to the Incentive There may also be factors external to the incentive that influence providers’ responses –Some may enable or facilitate a provider’s response (or prevent response), e.g.:  Organizational characteristics of the provider’s group (e.g., IT capabilities, interest in improving performance)  Patient factors (e.g., education level, willingness to take on self-care)

Design of the Incentive Program: Financial aspects (e.g., revenue potential, cost of compliance) Reputational aspects (e.g., extent of efforts to market data to patients and peers) Psychological dimensions (e.g., salience of quality measures to provider’s practice) Patient factors (e.g., education, income, cost sharing) Provider decision-maker Hospital or Medical Gp Hospital and provider response: change in care structure or process Outcomes--change in: Clinical performance measures Non-financial outcomes for the provider (e.g., provider satisfaction) Financial results for the provider Environmental variables: General approach to payment; regulatory and market factors Organizational factors (if applicable, e.g., the organization’s internal incentive programs and capabilities)

The Conceptual Model: Implications In designing VBP strategies, one must consider not only the obvious issues about revenue potential of financial incentives, but also: –Costs of complying with performance goals –The potential of non-financial incentives (esp. public reporting and consumer education programs) –Predisposing and enabling factors external to the incentive: general financial environment, provider traits, organizational effects, patient factors The same considerations are necessary when interpreting the literature on VBP

The Literature On VBP: What is Already Known? In general, there is very little literature: –Only 9 randomized trials of any kind of incentive strategy in which the impact on quality is actually measured. –Other randomized trials of incentives to reduce utilization, but with no corresponding determination of whether the care eliminated would have been appropriate or not (so these are not studies of incentives for quality)

The Literature On VBP: Results First two caveats: –Since so many crucial variables are left out of all studies, conclusions cannot be firm –Since several important variables are not included in any study, the potential for these factors to change the observed results of these studies is unknown –This means users of this data must be cautious and rely on their judgment in drawing lessons

The Literature On VBP: Results Two general findings: –In some circumstances, providers respond appropriately to financial incentives –In some circumstances, providers respond appropriately to public release of performance information The precise details of when and how to use these approaches remain murky, however

The Literature On VBP: Incentives Can Work In some circumstances, providers respond to financial incentives: Hickson et al. Pediatrics 1987;80(3):344 –Paid residents their salary plus $2/visit scheduled vs. $20/month for attending clinic –FFS-incentivized residents did better complying with well-child care recommendations and continuity…for $2!

The Literature On VBP: Incentives Can Work In some circumstances, providers respond to non-financial incentives: –Hibbard et al. Health Affairs 2003;22(4):84 –Highlighting this study because it is unique

Best practices around c-sections Best practices around v-bacs Reducing 3rd or 4th degree laceration Average number of quality improvement activities to reduce obstetrical complications: Public report group has more QUALITY IMPROVEMENT (p <.01, n = 93) Reducing hemorrhage Reducing pre-natal complications Reducing post-surgical complications Other

Hospitals with poor OB scores: Public report group have the most OB QI activities (p =.001, n = 34)

Hospitals with poor OB score: Public report group have more QI on reducing hemorrhage – a key factor in the poor scores (p <.001, N=34)

The Literature On VBP: Results by Topic Magnitude of incentive: –$2 /visit incentive worked for residents with relatively few other costs, incentives, or income opportunities –Others have shown small incentives (e.g., $0.80/flu shot) can have an effect for vaccines (low costs of compliance) –Incentives of $10,000 ineffective for tobacco cessation (high costs of compliance) –Certainty may matter: only negative immunization study was one in which the incentive was a 15% chance of getting a bonus of $500-2,000

The Literature On VBP: Results by Topic Structure of the incentive –FFS: 4 positive studies, one negative –Bonus for hitting a compliance rate target: two positive, three negative (two negative were for a ~15% chance of getting a bonus if performance better than other groups) –Non-financial incentives Public report: one positive study

The Literature On VBP: Results by Topic Recipient/Targets of Incentive: –Physicians (7 studies, 9 dependent variables) 5 positive 4 negative –Pharmacists: one positive study –Hospitals: one positive study –(Other factors seem more important)

The Literature On VBP: Results by Topic Preventive care (7 studies, 9 dependent variables) –5 positive (3 immunizations, 1 well-child, 1 tobacco screening) –4 negative (1 cancer screening, 1 well-child, 1 immunizations, 1 tobacco cessation) Chronic care: one positive study Acute care: one positive study

The Literature On VBP: Results by Topic Patient factors: –Goals likely to encounter fewer patient barriers (immunizations, asking about smoking): mostly positive –Goals that required modest patient cooperation (e.g., well child visits and cancer screening): mixed –Goals that require significant patient cooperation (e.g., smoking cessation): negative

The Literature On VBP: Topics NOT! Covered For determining revenue potential: % of providers’ income from study patients The direct, opportunity costs of complying (or not) Most potentially predisposing factors, such as: –general mix of reimbursement providers faced (e.g., % FFS vs. % capitation, number of other incentive programs offered) –individual characteristics of the provider Organizational enabling/inhibiting factors

The Literature On VBP: Summary Fairly difficult to interpret and generalize However, some factors identified in the conceptual model do seem to matter –Revenue potential (and certainty of gain) –Costs and difficulty of meeting goals –Enabling/inhibiting factors at the patient level

The Literature On VBP: Summary Other potentially important factors have not been studied –Predisposing factors (general financial incentive environment, physician factors) –Specific of costs and difficulty of meeting goals –Enabling/inhibiting factors at the organizational level

The Literature On VBP: Summary Non-financial incentives, esp. public reports, seem as worthy of further consideration as financial incentives –Caveat: provider interviews suggest that, without subsequent use of payment incentives, the response to public reports may wane; the positive studies reported here measured short term responses –(Mehrotra et al, Health Affairs, 2003; 22(2):60) Even these tepid conclusions reflect our judgment and extrapolation, to some extent

The Literature On Financial Incentives: Summary Repeat for emphasis: –There has been no research on the impact of organizational factors –Why this is so important: Much of the priority setting for providers and most investments to improve come from the organization

Reasons for Optimism about VBP and VBP Research The system environment and physician expectations are changing –Using incentives to encourage quality (and measuring quality) was unacceptable a few years ago; resistance seems lower now –Information systems are still crude, but becoming better You’ll hear in subsequent talks about some ongoing research

Summary Literature on VBP is weak and incomplete This reflects the historical difficulty of initiating projects…but it’s now easier and interesting studies are ongoing

Summary From every other business arena, we know incentives work Three missing ingredients before today: –Political will –A conceptual model to guide users to look for opportunities and pitfalls (test the one you saw today) –A wide variety of valid performance indicators